ARCHIVES

Physician Bonus Denied Some Agencies; NIH Status Unsure

This article is from The Cancer Letter archive.

Vol. 17 No. 03 | January 18, 1991

Download PDF Visit The Full Archive

Related Articles

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

October 9, 1987

To Review Cancer Bioinformatics Grid

November 12, 2010

ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication

February 17, 2012

ACS Issues Challenge To cut Death Rate From Cancer In Half

November 22, 1996

House Appropriations by Institute

July 8, 1994